Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 10, 2022Journal of Infection and Public HealthOpen Access

Development and research progress of anti-drug resistant fungal drugs

View Full Paper
Ask AI
Bookmark
Share

Authors

XCXiangyi CuiYan'an UniversityLWLanlin WangYan'an UniversityYLYuhong LüChinese Academy of Medical Sciences & Peking Union Medical College

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cui et al. (2022) studied this question.

synapsesocial.com/papers/6a7b90132305edf9bbed15cahttps://doi.org/10.1016/j.jiph.2022.08.004
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Acylhydrazones as Antifungal Agents Targeting the Synthesis of Fungal Sphingolipids2018 · 73 citations
  2. 2Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida species2013 · 130 citations
  3. 3Combination of fluconazole with silver nanoparticles produced byFusarium oxysporumimproves antifungal effect against planktonic cells and biofilm of drug-resistantCandida albicans2015 · 77 citations
  4. 4Antifungal Spectrum, In Vivo Efficacy, and Structure–Activity Relationship of Ilicicolin H2012 · 65 citations
  5. 5Molecular Evolution of Antifungal Drug Resistance2017 · 458 citations